Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor

Journal of Neurology

Volumn 240, Issue 3, 1993, Pages 156-160

  Faes, T J C ^a   Yff, G A ^a   De Weerdt, O ^a   Lanting, P ^a   Heimans, J J ^a   Bertelsmann, F W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aldose reductase inhibitor; Autonomic neuropathy; Diabetes mellitus; Reliability test

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; PONALRESTAT;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR REFLEX; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUPIL REFLEX; SYMPTOM; VASOMOTOR REFLEX;

ALDEHYDE REDUCTASE; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MIDDLE AGE; PHTHALAZINES; REPRODUCIBILITY OF RESULTS;

EID: 0027538074     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/BF00857521     Document Type: Article

References (32)

1. A study of peripheral diabetic neuropathy. The application of age-related reference values
2. A multicentre trial of the aldose reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy
3. Diabetic neuropathy
4. The effect of an aldose reductase inhibitor (sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study
5. Quantitation of skin vasomotor control in normal subjects and in diabetic patients with autonomic neuropathy
6. The Rochester diabetic neuropathy study: design, criteria for types of neuropathy, selection bias and reproducibility of tests
7. Vascular reflexes in diabetic autonomic neuropathy
8. Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes
9. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy: a clinical and neurophysiological study
10. Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial
11. Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy
12. The sorbitol pathway and the complications of diabetes
13. Effect of the aldose reductase inhibitor, ponalrestat, on diabetic neuropathy
14. Myoinositol and sorbitol metabolism in relation the peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition
15. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor
16. Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy
17. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients
18. Variability of three standard neurophysiological techniques in established symptomatic diabetic polyneuropathy
19. Assessment of pupillary light reflex latency and darkness adapted pupil size in control subjects and in diabetic patients with and without cardiovascular autonomic neuropathy
20. Clinical and neurophysiological studies with the aldose reductase inhibitor sorbinil, in symptomatic diabetic neuropathy
21. The influence of autonomic neuropathy in mortality in insulin-dependent diabetes
22. Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil
23. Assessment of pupillary function in diabetic neuropathy
24. Properties of ICI 128, 436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat
25. Respiratory influence on heart rate in diabetes mellitus
26. Autonomic and peripheral nerve function in early diabetic neuropathy
27. Clinical observations and experiments in diabetic neuropathy
28. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy
29. One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy